pillbase.ru

Teriparatide

Active substance: teriparatide

INJECTION, SOLUTION · TERIPARATIDE ACETATE 250 ug/mL

United StatesActive

Marketing holder: Teva Pharmaceuticals USA, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 12
  • Forsteo
    teriparatide
    EMEA/H/C/000425
    Eli Lilly Nederland B.V.
  • Kauliv
    teriparatide
    EMEA/H/C/004932
    Strides Pharma (Cyprus) Limited
  • Livogiva
    teriparatide
    EMEA/H/C/005087
    Theramex Ireland Limited
  • Movymia
    teriparatide
    EMEA/H/C/004368
    STADA Arzneimittel AG
  • Sondelbay
    teriparatide
    EMEA/H/C/005827
    Accord Healthcare S.L.U.
All products in this country (12)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-501e-73a3-938c-141efa9f8d6b,01a1208f-bc0b-7b0f-b166-b5e0785dadf2,01a12091-6e33-7d46-829c-56d8596febac,01a12094-4932-732d-be81-29d087436b50,01a12097-eeb1-7f57-9eee-25adc10ef224;count=10 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0093-1106
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 0093-1106 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0093-1106 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0093-1106 · Verified 2026-10-09 · open in source